Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Radiation Injuries 1Gangliosidosis, GM1 1Gangliosidoses 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × G(M1) Ganglioside × Clear all
NCT04395339 2024-08-01

GLORY

Sun Yat-sen University

Phase 3 Terminated
51 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction

NCT02251977 2019-10-07

Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer

Sun Yat-sen University

Phase 3 Completed
196 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡